Cipla acquires Inzpera to enhance pediatric healthcare portfolio
pre-market1 source ↓written by the desknot a recommendation
- in Inzpera Healthsciences
- 100% stake
- Inzpera Healthsciences
- ₹110.65 crore
Cipla has acquired a 100% stake in Inzpera Healthsciences for ₹110.65 crore, expanding its specialty portfolio into pediatric healthcare. Inzpera focuses on pediatric pharmaceuticals and nutritional wellness, addressing growing demand in India. This strategic move aligns with Cipla's goal to diversify into high-growth therapeutic segments.
Not investment advice. For informational purposes only.